Table 1.
Descriptive characteristics of the study population according to physical activity pattern
| Physical activity pattern (n=2015) | ||||
|---|---|---|---|---|
| Characteristic | Total population (n=2363) | Insufficiently active (n=173) | Weekend warrior (n=494) | Regularly active (n=1348) |
| Age (years) | 61.0 (55.0–66.0) | 64.0 (59.0–70.0) | 63.0 (56.0–67.0) | 60.0 (54.0–66.0) |
| Sex (% male) | 51.5 | 76.3 | 57.3 | 44.6 |
| Education level (%) | ||||
| Low | 33.5 | 50.9 | 33.0 | 31.1 |
| Medium | 28.1 | 28.9 | 24.3 | 28.6 |
| High | 38.4 | 20.2 | 42.7 | 40.4 |
| Smoking status (%) | ||||
| Current | 12.5 | 24.9 | 10.1 | 10.3 |
| Former | 52.2 | 53.2 | 52.4 | 52.0 |
| Never | 35.3 | 22.0 | 37.4 | 37.7 |
| Alcohol consumption (%) | ||||
| None | 17.6 | 28.9 | 14.0 | 16.9 |
| Low | 57.0 | 54.9 | 56.7 | 57.3 |
| High | 25.4 | 16.2 | 29.4 | 25.8 |
| Mobility limitations (%) | ||||
| Yes | 20.3 | 46.8 | 17.8 | 17.4 |
| No | 79.7 | 53.2 | 82.2 | 82.6 |
| BMI (kg/m2) | 27.02 (4.54) | 30.11 (5.51) | 26.82 (4.09) | 26.42 (4.11) |
| History of CVD (%) | 16.6 | 30.1 | 16.4 | 15.0 |
| Diabetes status (%) | ||||
| Normal | 55.5 | 23.1 | 55.7 | 61.6 |
| Impaired | 15.1 | 10.4 | 16.8 | 14.8 |
| Type 2 diabetes | 28.3 | 64.7 | 26.7 | 22.4 |
| Other type of diabetes | 1.1 | 1.7 | 0.8 | 1.2 |
| Antihypertensive medication use (%) | 41.4 | 69.4 | 42.7 | 37.8 |
| Lipid-modifying medication use (%) | 37.7 | 64.2 | 37.9 | 32.9 |
| Glucose-lowering medication use (%) | 23.7 | 58.4 | 21.7 | 18.4 |
| Total cholesterol/HDL-cholesterol ratio | 3.38 (2.76–4.19) | 3.64 (3.00–4.60) | 3.45 (2.82–4.29) | 3.28 (2.70–4.06) |
| Triacylglycerol (mmol/l) | 1.22 (0.89–1.72) | 1.54 (1.12–2.14) | 1.25 (0.90–1.75) | 1.16 (0.86–1.61) |
| Dutch healthy diet index | 83.73 (14.67) | 78.19 (14.80) | 84.39 (13.63) | 85.08 (14.81) |
| Valid days (n) | 7.0 (6.00–7.00) | 7.00 (6.00–7.00) | 7.0 (6.00–7.00) | 7.0 (6.00–7.00) |
| Sedentary time (h/day) | 9.42 (1.67) | 10.96 (1.51) | 9.66 (1.44) | 9.09 (1.55) |
| Total physical activity (h/day) | 1.96 (1.49–2.44) | 1.01 (0.81–1.21) | 1.85 (1.50–2.25) | 2.09 (1.68–2.55) |
| Light intensity physical activity (h/day) | 5.41 (1.52) | 4.12 (1.39) | 5.07 (1.30) | 5.69 (1.43) |
| Moderate-to-vigorous intensity physical activity (h/day) | 0.85 (0.58–1.15) | 0.27 (0.19–0.31) | 0.84 (0.64–1.10) | 0.94 (0.68–1.22) |
| Vigorous intensity physical activity (h/day) | 0.09 (0.04–0.19) | 0.02 (0.01–0.03) | 0.09 (0.05–0.18) | 0.10 (0.06–0.21) |
| Sedentary breaks (n/day) | 37.45 (8.58) | 33.17 (8.21) | 35.50 (7.63) | 38.51 (8.25) |
| Prolonged sedentary bouts (n/day) | 4.86 (3.71–5.86) | 6.29 (5.17–7.17) | 5.29 (4.33–6.14) | 4.46 (3.50–5.50) |
| sICAM-1 (ng/ml) | 355.62 (98.26) | 402.95 (144.46) | 353.75 (94.21) | 348.68 (85.17) |
| sVCAM-1 (ng/ml) | 428.50 (100.61) | 471.35 (135.04) | 432.68 (99.96) | 421.59 (91.75) |
| sE-selectin (ng/ml) | 117.81 (66.46) | 154.91 (112.77) | 114.12 (58.05) | 112.39 (59.95) |
| von Willebrand factor (%) | 132.20 (47.84) | 154.03 (52.48) | 134.60 (51.34) | 128.32 (44.64) |
| Plasma hs-CRP (mg/l) | 1.22 (0.61–2.72) | 1.99 (1.01–4.04) | 1.21 (0.64–2.84) | 1.12 (0.57–2.45) |
| Plasma SAA (μg/ml) | 3.36 (2.09–5.45) | 3.48 (2.10–6.89) | 3.30 (2.14–5.31) | 3.36 (2.04–5.36) |
| Plasma IL-6 (pg/ml) | 0.58 (0.39–0.90) | 0.89 (0.65–1.42) | 0.57 (0.42–0.87) | 0.55 (0.37–0.84) |
| Plasma IL-8 (pg/ml) | 4.11 (3.25–5.29) | 4.83 (3.89–6.42) | 4.23 (3.34–5.27) | 3.97 (3.19–5.13) |
| Plasma TNF-α (pg/ml) | 2.20 (1.89–2.56) | 2.50 (2.19–3.00) | 2.18 (1.86–2.55) | 2.16 (1.87–2.51) |
Values are means (SD) or median (Q1–Q3), unless stated otherwise